Cerivastatin Sodium

西立伐他汀钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCerivastatin Sodium
Drug Alias Name西立伐他汀cerivastatina西利伐他汀钠SeltaCholstat +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaDyslipidemias
Global Approved IndicationsHypercholesterolemiaDyslipidemias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/06/26
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Pharms Corp
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaDyslipidemias

Other Information

ATC CodeC10AA06
Related LinksWikipediaDrugBankKEGG